Nanthealth LLC (NYSE:NH) saw unusually-strong trading volume on Friday . Approximately 94,852 shares changed hands during mid-day trading, an increase of 42% from the previous session’s volume of 67,023 shares.The stock last traded at $11.24 and had previously closed at $10.60.

Several equities analysts have recently issued reports on NH shares. FBR & Co started coverage on Nanthealth in a research note on Monday, June 27th. They issued an “outperform” rating and a $18.00 price objective for the company. Cowen and Company started coverage on Nanthealth in a research note on Monday, June 27th. They issued an “outperform” rating and a $19.00 price objective for the company. First Analysis assumed coverage on Nanthealth in a research note on Monday, June 27th. They issued an “overweight” rating and a $18.00 price objective for the company. Canaccord Genuity assumed coverage on Nanthealth in a research report on Monday, June 27th. They set a “buy” rating and a $17.00 target price on the stock. Finally, Jefferies Group assumed coverage on Nanthealth in a research report on Monday, June 27th. They set a “buy” rating on the stock. Five equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average price target of $18.00.

The firm has a 50 day moving average of $11.64 and a 200 day moving average of $12.39. The firm’s market cap is $1.38 billion.

Nanthealth (NYSE:NH) last released its earnings results on Tuesday, August 9th. The company reported ($0.15) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.26. The business earned $31.50 million during the quarter, compared to analyst estimates of $23.55 million. The company’s quarterly revenue was up 166.9% compared to the same quarter last year. On average, equities research analysts forecast that Nanthealth LLC will post ($0.77) earnings per share for the current fiscal year.

In other Nanthealth news, CEO Patrick Soon-Shiong purchased 357,143 shares of Nanthealth stock in a transaction that occurred on Tuesday, June 7th. The stock was purchased at an average price of $14.00 per share, with a total value of $5,000,002.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Healthcare Solution Allscripts purchased 714,286 shares of Nanthealth stock in a transaction that occurred on Tuesday, June 7th. The stock was acquired at an average cost of $14.00 per share, with a total value of $10,000,004.00. Following the acquisition, the insider now directly owns 15,000,000 shares of the company’s stock, valued at approximately $210,000,000. The disclosure for this purchase can be found here.

Nant Health, LLC is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.